Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Circulation
    January 2018
  1. IANIRO G, Cammarota G, Gasbarrini A
    Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium".
    Circulation. 2018;137:213-214.
    >> Share


  2. Correction to: 2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular
    Circulation. 2018;137:e14.
    >> Share

    December 2017
  3. GIUGLIANO RP, Cannon CP, Blazing MA, Nicolau JC, et al
    Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT.
    Circulation. 2017 Dec 20. pii: CIRCULATIONAHA.117.030950.
    >> Share


  4. Correction to: Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2017;136:e469.
    >> Share

  5. BENSON MD, Yang Q, Ngo D, Zhu Y, et al
    The Genetic Architecture of the Cardiovascular Risk Proteome.
    Circulation. 2017 Dec 19. pii: CIRCULATIONAHA.117.029536.
    >> Share


  6. Correction to: 2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2017;136:e468.
    >> Share

  7. PAZOKI R, Dehghan A, Evangelou E, Warren H, et al
    Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations with Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2017 Dec 18. pii: CIRCULATIONAHA.117.030898.
    >> Share

  8. GOLDSTONE AB, Chiu P, Baiocchi M, Wang H, et al
    Second Arterial versus Venous Conduits for Multi-Vessel Coronary Artery Bypass Surgery in California.
    Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.030959.
    >> Share

  9. GAO L, Gregorich ZR, Zhu W, Mattapally S, et al
    Large Cardiac-Muscle Patches Engineered from Human Induced-Pluripotent Stem-Cell-Derived Cardiac Cells Improve Recovery from Myocardial Infarction in Swine.
    Circulation. 2017 Dec 12. pii: CIRCULATIONAHA.117.030785.
    >> Share

  10. AHN JM, Park SJ
    Response by Ahn and Park to Letter Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)"
    Circulation. 2017;136:2393-2394.
    >> Share

  11. JIN-SHAN H, Xue-Bin L
    Letter by Jin-Shan and Xue-Bin Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)".
    Circulation. 2017;136:2392.
    >> Share

  12. HAN YL, Rutherford JD
    Recent Evolution of the Treatment of Coronary Artery Disease in China: A Conversation With Ya-Ling Han, MD, PhD.
    Circulation. 2017;136:2298-2302.
    >> Share

  13. FRANKENREITER S, Bednarczyk P, Kniess A, Bork NI, et al
    cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Circulation. 2017;136:2337-2355.
    >> Share

  14. ZHANG L, Wei TT, Li Y, Li J, et al
    Functional Metabolomics Characterizes a Key Role for N-Acetyl-Neuraminic Acid in Coronary Artery Diseases.
    Circulation. 2017 Dec 6. pii: CIRCULATIONAHA.117.031139.
    >> Share

    November 2017
  15. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)".
    Circulation. 2017;136:2202-2203.
    >> Share

  16. YAN W, Guo Y, Tao L, Lau WB, et al
    C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.
    Circulation. 2017;136:2162-2177.
    >> Share

  17. KOSKINEN J, Juonala M, Dwyer T, Venn A, et al
    Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: The International Childhood Cardiovascular Cohort (i3C) Consortium.
    Circulation. 2017 Nov 23. pii: CIRCULATIONAHA.117.029726.
    >> Share

  18. HORCKMANS M, Bianchini M, Santovito D, Megens RTA, et al
    Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.028833.
    >> Share

  19. JENSEN MK, Aroner SA, Mukamal KJ, Furtado JD, et al
    HDL Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
    Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.031276.
    >> Share

  20. CICCARELLI G, Barbato E, Toth GG, Gahl B, et al
    Angiography versus Hemodynamics to Predict the Natural History of Coronary Stenoses: A FAME 2-Substudy.
    Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.028782.
    >> Share

  21. CHAPMAN AR, Shah ASV, Lee KK, Anand A, et al
    Long Term Outcomes in Patients with Type 2 Myocardial Infarction and Myocardial Injury.
    Circulation. 2017 Nov 17. pii: CIRCULATIONAHA.117.031806.
    >> Share

  22. LEHMANN N, Erbel RA, Mahabadi AA, Rauwolf M, et al
    Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the Heinz Nixdorf Recall (HNR) Study.
    Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.116.027034.
    >> Share

  23. JOLLIS JG, Al-Khalidi HR, Roettig ML, Berger PB, et al
    Impact of Regionalization of ST Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services Transported Patients Presenting to Hospitals with Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.
    Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.032446.
    >> Share

  24. THAN MP, Pickering JW, Dryden JM, Lord SJ, et al
    ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway.
    Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.031984.
    >> Share

  25. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Response by Perez de Isla et al to Letter Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1984.
    >> Share

  26. NATALE F, Di Maio M, Calabro P
    Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1982-1983.
    >> Share

  27. KHERA R, Hong JC, Saxena A, Arrieta A, et al
    Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.030128.
    >> Share

  28. UDELL JA, Yuan Z, Rush T, Sicignano NM, et al
    Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Co-Transporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.031227.
    >> Share

  29. BONACA MP, Nault P, Giugliano RP, Keech AC, et al
    Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032235.
    >> Share

  30. MAHAFFEY KW, Neal B, Perkovic V, de Zeeuw D, et al
    Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032038.
    >> Share

  31. VERMA S, Mazer CD, Al-Omran M, Inzucchi SE, et al
    Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032031.
    >> Share

  32. BURSTEIN B, Altobelli KK, Williams K, Cannon CP, et al
    Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Circulation. 2017;136:1860-1862.
    >> Share

  33. DRAGER LF, McEvoy RD, Barbe F, Lorenzi-Filho G, et al
    Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.
    Circulation. 2017;136:1840-1850.
    >> Share

  34. LEE JM, Hwang D, Park J, Zhang J, et al
    Exploring Coronary Circulatory Response to Stenosis and Its Association With Invasive Physiologic Indexes Using Absolute Myocardial Blood Flow and Coronary Pressure.
    Circulation. 2017;136:1798-1808.
    >> Share

  35. OLASVEENGEN TM, de Caen AR, Mancini ME, Maconochie IK, et al
    2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000541.
    >> Share

  36. ATKINS DL, de Caen AR, Berger S, Samson RA, et al
    2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000540.
    >> Share

  37. KLEINMAN ME, Goldberger ZD, Rea T, Swor RA, et al
    2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000539.
    >> Share

  38. TWERENBOLD R, Badertscher P, Boeddinghaus J, Nestelberger T, et al
    0/1-Hour Triage Algorithm for Myocardial Infarction in Patients with Renal Dysfunction.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028901.
    >> Share

  39. FEARON WF, Nishi T, De Bruyne B, Boothroyd DB, et al
    Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Mul
    Circulation. 2017 Nov 2. pii: CIRCULATIONAHA.117.031907.
    >> Share

    October 2017
  40. GAUDINO M, Antoniades C, Benedetto U, Deb S, et al
    Mechanisms, Consequences, and Prevention of Coronary Graft Failure.
    Circulation. 2017;136:1749-1764.
    >> Share

  41. HENG EL, Gatzoulis MA, Uebing A, Sethia B, et al
    Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study.
    Circulation. 2017;136:1703-1713.
    >> Share

  42. IRIBARNE A, Schmoker JD, Malenka DJ, Leavitt BJ, et al
    Does Use of Bilateral Internal Mammary Artery Grafting Reduce Long-Term Risk of Repeat Coronary Revascularization? A Multicenter Analysis.
    Circulation. 2017;136:1676-1685.
    >> Share

  43. RUEL M, Gardner TJ
    Introduction to the 2017 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2017;136:1675.
    >> Share

  44. KRITTANAWONG C
    Future Physicians in the Era of Precision Cardiovascular Medicine.
    Circulation. 2017;136:1572-1574.
    >> Share

  45. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    >> Share

  46. CARNETHON MR, Pu J, Howard G, Albert MA, et al
    Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
    >> Share

  47. MCEVOY JW, Ibrahim K, Kickler TS, Clarke WA, et al
    Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial.
    Circulation. 2017 Oct 18. pii: CIRCULATIONAHA.117.031678.
    >> Share

  48. VAN DIEPEN S, Katz JN, Albert NM, Henry TD, et al
    Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e232-e268.
    >> Share

  49. BORTOLOTTI F, Ruozi G, Falcione A, Doimo S, et al
    In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells.
    Circulation. 2017;136:1509-1524.
    >> Share

  50. MAGNUSSEN C, Niiranen TJ, Ojeda F, Gianfagna F, et al
    Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
    Circulation. 2017 Oct 16. pii: CIRCULATIONAHA.117.028981.
    >> Share

  51. MCCARROLL CS, He W, Foote K, Bradley A, et al
    Runx1 Deficiency Protects Against Adverse Cardiac Remodeling Following Myocardial Infarction.
    Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.117.028911.
    >> Share

  52. SUNA G, Wojakowski W, Lynch M, Barallobre-Barreiro J, et al
    Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.
    Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.116.023381.
    >> Share

  53. SUNDBOLL J, Hovath-Puho E, Adelborg K, Schmidt M, et al
    Higher Risk of Vascular Dementia in Myocardial Infarction Survivors.
    Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.029127.
    >> Share

  54. HASEEB S, Alexander B, Baranchuk A
    Wine and Cardiovascular Health: A Comprehensive Review.
    Circulation. 2017;136:1434-1448.
    >> Share

  55. LACRAZ GPA, Junker JP, Gladka MM, Molenaar B, et al
    Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury.
    Circulation. 2017;136:1396-1409.
    >> Share

  56. MILLER-HODGES EV, Anand A, Shah ASV, Chapman AR, et al
    High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients with Renal Impairment Presenting with Suspected Acute Coronary Syndrome.
    Circulation. 2017 Oct 4. pii: CIRCULATIONAHA.117.030320.
    >> Share

  57. SMOLDEREN KGE, Gosch KG, Buchanan DM, Spertus JA, et al
    Response by Smolderen et al to Letter Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial
    Circulation. 2017;136:1355-1356.
    >> Share

  58. MA LL, Kong FJ, Ge JB
    Letter by Ma et al Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients
    Circulation. 2017;136:1353-1354.
    >> Share

  59. HEAD SJ, Milojevic M, Taggart DP, Puskas JD, et al
    Current Practice of State-of-the-Art Surgical Coronary Revascularization.
    Circulation. 2017;136:1331-1345.
    >> Share

    September 2017
  60. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    >> Share

  61. BERRY C, McClure JD, Oldroyd KG
    Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.030430.
    >> Share

  62. GOYAL A, Gluckman TJ, Tcheng JE
    What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction.
    Circulation. 2017;136:1180-1182.
    >> Share

  63. WILSON PWF, Gagnon D
    Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual Care.
    Circulation. 2017;136:1204-1206.
    >> Share

  64. SUNDSTROM J, Hedberg J, Thuresson M, Aarskog P, et al
    Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study.
    Circulation. 2017;136:1183-1192.
    >> Share

  65. KAIER TE, Twerenbold R, Puelacher C, Marjot J, et al
    Direct Comparison of Cardiac Myosin-Binding Protein C with Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028084.
    >> Share

  66. REBOLL MR, Korf-Klingebiel M, Klede S, Polten F, et al
    Endoplasmic Reticulum Membrane Protein Complex Subunit 10 (EMC10) is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
    Circulation. 2017 Sep 20. pii: CIRCULATIONAHA.117.029980.
    >> Share

  67. CREA F, Libby P
    Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.
    Circulation. 2017;136:1155-1166.
    >> Share

  68. QUAIFE-RYAN GA, Sim CB, Ziemann M, Kaspi A, et al
    Multicellular Transcriptional Analysis of Mammalian Heart Regeneration.
    Circulation. 2017;136:1123-1139.
    >> Share

  69. NALLAMOTHU BK, Hill JA
    Preprints and Cardiovascular Science: Prescient or Premature?
    Circulation. 2017 Sep 14. pii: CIRCULATIONAHA.117.031238.
    >> Share

  70. WANNER C, Lachin JM, Inzucchi SE, Fitchett D, et al
    Empagliflozin and Clinical Outcomes in Patients with Type 2 Diabetes, Established Cardiovascular Disease and Chronic Kidney Disease.
    Circulation. 2017 Sep 13. pii: CIRCULATIONAHA.117.028268.
    >> Share

  71. LINDAHL B, Baron T, Erlinge D, Hadziosmanovic N, et al
    Response by Lindahl et al to Letter Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
    Circulation. 2017;136:1082-1083.
    >> Share

  72. CILIBERTI G, Capucci A
    Letter by Ciliberti and Capucci Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
    Circulation. 2017;136:1080-1081.
    >> Share

  73. DEHARO P, Ducrocq G, Bode C, Cohen M, et al
    Timing of Angiography and Outcomes in High-Risk Patients with Non-ST Segment Elevation Myocardial Infarction Managed Invasively: Insights from the TAO Trial.
    Circulation. 2017 Sep 11. pii: CIRCULATIONAHA.117.029779.
    >> Share

  74. HUANG C, Moran AE, Coxson PG, Yang X, et al
    Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China.
    Circulation. 2017 Sep 7. pii: CIRCULATIONAHA.116.026487.
    >> Share

  75. VALLEJO-VAZ AJ, Robertson M, Catapano AL, Watts GF, et al
    LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.027966.
    >> Share

  76. GOLDWASSER D, Elizari MV, Bayes de Luna A
    Chronic Myocardial Infarction: Where Is It Located?
    Circulation. 2017;136:966-968.
    >> Share

  77. HAUSENLOY DJ, Yellon DM
    Combination Therapy to Target Reperfusion Injury After ST-Segment-Elevation Myocardial Infarction: A More Effective Approach to Cardioprotection.
    Circulation. 2017;136:904-906.
    >> Share


  78. Correction to: Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2017;136:e197.
    >> Share


  79. Correction to: Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2017;136:e195.
    >> Share

  80. HUNTER AL, Mills NL
    Response by Hunter and Mills to Letters Regarding Article, "Fire Simulation and Cardiovascular Health in Firefighters".
    Circulation. 2017;136:976-977.
    >> Share

  81. JIN-SHAN H, Xue-Bin L
    Letter by Jin-Shan and Xue-Bin Regarding Article, "Fire Simulation and Cardiovascular Health in Firefighters".
    Circulation. 2017;136:974-975.
    >> Share

  82. JIANG XW, Yang CZ, Qiao SB
    Letter by Jiang et al Regarding Article, "Fire Simulation and Cardiovascular Health in Firefighters".
    Circulation. 2017;136:973.
    >> Share

  83. KAPPEL BA, Lehrke M, Schutt K, Artati A, et al
    Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease.
    Circulation. 2017;136:969-972.
    >> Share

  84. GUPTA A, Taqueti VR, van de Hoef TP, Bajaj NS, et al
    Integrated Non-invasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients with Stable Coronary Artery Disease.
    Circulation. 2017 Sep 1. pii: CIRCULATIONAHA.117.029992.
    >> Share

    August 2017
  85. NAUCK MA, Meier JJ, Cavender MA, Abd El Aziz M, et al
    Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
    Circulation. 2017;136:849-870.
    >> Share

  86. ZIAEIAN B, Fonarow GC
    Maximizing Cardiovascular Event Reduction by Expanding and Intensifying the Targets.
    Circulation. 2017;136:813-816.
    >> Share

  87. WANG WE, Li L, Xia X, Fu W, et al
    Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury.
    Circulation. 2017;136:834-848.
    >> Share

  88. BUDOFF MJ, Mayrhofer T, Ferencik M, Bittner DO, et al
    The Prognostic Value of Coronary Artery Calcium in the PROMISE Study.
    Circulation. 2017 Aug 28. pii: CIRCULATIONAHA.117.030578.
    >> Share

  89. PU J, Ding S, Ge H, Han Y, et al
    Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Ac
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030582.
    >> Share

  90. PUYMIRAT E, Simon T, Cayla G, Cottin Y, et al
    Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-elevation Myocardial Infarction) 1995 to 2015.
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030798.
    >> Share

  91. WISETH R, Bonaa KH
    Potential Implications of NORSTENT (Norwegian Coronary Stent Trial) in Contemporary Practice.
    Circulation. 2017;136:701-703.
    >> Share

  92. FIOL-SALA M, Bayes de Luna A
    Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?
    Circulation. 2017;136:691-693.
    >> Share

  93. GIBBONS GH
    Charting Our Future Together: Turning Discovery Science Into Cardiovascular Health.
    Circulation. 2017;136:615-617.
    >> Share

  94. KANDZARI DE, Smits PC, Love MP, Ben-Yehuda O, et al
    Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease: Primary Results from the BIONICS Trial.
    Circulation. 2017 Aug 9. pii: CIRCULATIONAHA.117.028885.
    >> Share

  95. SARDELLA G, Mancone M, Stio RE, Cavallo E, et al
    Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.
    Circulation. 2017;136:602-604.
    >> Share

  96. BERRY C
    Stable Coronary Syndromes: The Case for Consolidating the Nomenclature of Stable Ischemic Heart Disease.
    Circulation. 2017;136:437-439.
    >> Share

  97. TAGGART DP, Altman DG, Flather M, Gerry S, et al
    Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization Trial.
    Circulation. 2017;136:454-463.
    >> Share

    July 2017
  98. ADAY AW, MacRae CA
    Genomic Medicine in Cardiovascular Fellowship Training.
    Circulation. 2017;136:345-346.
    >> Share

  99. ADRIAENSSENS T, Joner M, Godschalk T, Malik N, et al
    Optical Coherence Tomography Findings in Patients with Coronary Stent Thrombosis: A Report of the PREvention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Consortium.
    Circulation. 2017 Jul 18. pii: CIRCULATIONAHA.117.026788.
    >> Share

  100. HERNAEZ A, Castaner O, Fito M
    Response to Letter Regarding Article, "Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial".
    Circulation. 2017;136:342-343.
    >> Share

  101. LEGGIO M, Bendini MG, Mazza A
    Letter by Leggio et al Regarding Article, "Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial".
    Circulation. 2017;136:340-341.
    >> Share

  102. LERMAN JB, Joshi AA, Chaturvedi A, Aberra TM, et al
    Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.
    Circulation. 2017;136:263-276.
    >> Share

  103. COLANTONIO LD, Gamboa CM, Richman JS, Levitan EB, et al
    Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease.
    Circulation. 2017;136:152-166.
    >> Share

  104. TAQUETI VR, Di Carli MF
    Response by Taqueti and Di Carli to Letter Regarding Article, "Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease".
    Circulation. 2017;136:241-242.
    >> Share

  105. ZIMMERMANN FM, Zelis JM, Van't Veer M
    Letter by Zimmermann et al Regarding Article, "Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease".
    Circulation. 2017;136:239-240.
    >> Share

  106. BAGGISH AL, Levine BD
    Coronary Artery Calcification Among Endurance Athletes: "Hearts of Stone".
    Circulation. 2017;136:149-151.
    >> Share

  107. DE COUTO G, Gallet R, Cambier L, Jaghatspanyan E, et al
    Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning.
    Circulation. 2017;136:200-214.
    >> Share

  108. FERNANDEZ-JIMENEZ R, Barreiro-Perez M, Martin-Garcia A, Sanchez-Gonzalez J, et al
    Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.116.025582.
    >> Share

  109. HELLER DJ, Coxson PG, Penko J, Pletcher MJ, et al
    Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027067.
    >> Share

  110. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    >> Share

  111. MAO G, Songdej N, Voora D, Goldfinger LE, et al
    Transcription Factor RUNX1 Regulates Platelet PCTP (Phosphatidylcholine Transfer Protein): Implications for Cardiovascular Events Differential Effects of RUNX1 Variants.
    Circulation. 2017 Jul 4. pii: CIRCULATIONAHA.116.023711.
    >> Share

  112. GIBSON CM, Fox K
    Response by Gibson and Fox to Letter Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonis
    Circulation. 2017;136:117.
    >> Share

  113. CERIT L
    Letter by Cerit Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy"
    Circulation. 2017;136:115-116.
    >> Share

  114. LEFER DJ, Marban E
    Is Cardioprotection Dead?
    Circulation. 2017;136:98-109.
    >> Share

  115. ASRRESS KN, Williams R, Lockie T, Khawaja MZ, et al
    Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise.
    Circulation. 2017;136:24-34.
    >> Share

    June 2017
  116. OLDE ENGBERINK RHG, van den Hoek TC, van Noordenne ND, van den Born BH, et al
    Use of a Single Baseline Versus Multi-Year 24-Hour Urine Collections for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk.
    Circulation. 2017 Jun 27. pii: CIRCULATIONAHA.117.029028.
    >> Share

  117. KRISHNAMOORTHY B, Critchley WR, Thompson AJ, Payne K, et al
    A Study Comparing Vein Integrity and Clinical Outcomes (VICO) in Open Vein Harvesting and Two Types of Endoscopic Vein Harvesting for Coronary Artery Bypass Grafting: The VICO Randomised Clinical Trial.
    Circulation. 2017 Jun 21. pii: CIRCULATIONAHA.117.028261.
    >> Share

  118. PASUPATHY S, Tavella R, Grover S, Raman B, et al
    Early use of N-Acetylcysteine (NAC) with Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The NACIAM Trial).
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027575.
    >> Share

  119. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    >> Share

  120. PAGIDIPATI NJ, Navar AM, Pieper KS, Green JB, et al
    Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes: International Insights from the TECOS Trial.
    Circulation. 2017 Jun 16. pii: CIRCULATIONAHA.117.027252.
    >> Share

  121. SACKS FM, Lichtenstein AH, Wu JHY, Appel LJ, et al
    Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2017 Jun 15. pii: CIR.0000000000000510.
    >> Share

  122. BIVARD A, Muir K, Parsons M
    Response by Bivard et al to Letter Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1141-e1142.
    >> Share

  123. ROOZENBEEK B, Dippel DWJ, Lingsma HF
    Letter by Roozenbeek et al Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1139-e1140.
    >> Share

  124. SATTAR N, Preiss D
    Reverse Causality in Cardiovascular Epidemiological Research: More Common Than Imagined?
    Circulation. 2017;135:2369-2372.
    >> Share

  125. SALEHEEN D, Zhao W, Young R, Nelson CP, et al
    Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions.
    Circulation. 2017;135:2336-2353.
    >> Share

  126. MCEVOY JW, Blaha MJ
    Response by McEvoy and Blaha to Letter Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1113-e1114.
    >> Share

  127. HARBAOUI B, Courand PY, Lantelme P
    Letter by Harbaoui et al Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1111-e1112.
    >> Share

    May 2017
  128. JOLLY SS, James S, Dzavik V, Cairns JA, et al
    Response by Jolly et al to Letters Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1103-e1104.
    >> Share

  129. SHAH R
    Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1101-e1102.
    >> Share

  130. JURADO-ROMAN A, Sanchez-Perez I, Lozano-Ruiz-Poveda F
    Letter by Jurado-Roman et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1099-e1100.
    >> Share

  131. KARAMASIS GV, Davies JR, Clesham GJ
    Letter by Karamasis et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1097-e1098.
    >> Share

  132. STRAUSS MH, Hall AS
    Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox.
    Circulation. 2017;135:2088-2090.
    >> Share

  133. MESSERLI FH, Bangalore S
    Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial Infarction.
    Circulation. 2017;135:2085-2087.
    >> Share

  134. DE ROOS A, van der Grond J, Mitchell G, Westenberg J, et al
    Magnetic Resonance Imaging of Cardiovascular Function and the Brain: Is Dementia a Cardiovascular-Driven Disease?
    Circulation. 2017;135:2178-2195.
    >> Share

  135. HUMPHRIES SE
    Common Variants for Cardiovascular Disease: Clinical Utility Confirmed.
    Circulation. 2017;135:2102-2105.
    >> Share

  136. MONTONE RA, Niccoli G, De Marco F, Minelli S, et al
    Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2017;135:2145-2154.
    >> Share

  137. ANTMAN EM
    Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs.
    Circulation. 2017;135:2062-2072.
    >> Share

  138. BAGGISH AL, Weiner RB, Kanayama G, Hudson JI, et al
    Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.
    Circulation. 2017;135:1991-2002.
    >> Share

  139. KARAM N, Bataille S, Marijon E, Tafflet M, et al
    Response by Karam et al to Letter Regarding Article, "Identifying Patients at Risk for Prehospital Sudden Cardiac Arrest at the Early Phase of Myocardial Infarction: The e-MUST Study (Evaluation en Medecine d'Urgence des Strategies Therapeutiques des
    Circulation. 2017;135:e1048-e1049.
    >> Share

  140. TUNCEZ A, Ates MS, Tezcan H
    Letter by Tuncez et al Regarding Article, "Identifying Patients at Risk for Prehospital Sudden Cardiac Arrest at the Early Phase of Myocardial Infarction: The e-MUST Study (Evaluation en Medecine d'Urgence des Strategies Therapeutiques des infarctus d
    Circulation. 2017;135:e1046-e1047.
    >> Share

  141. JOYNT KE
    Response to Outlier Status: Lessons From Public Reporting for Percutaneous Coronary Intervention.
    Circulation. 2017;135:1908-1910.
    >> Share

  142. RYDEN L, Mellbin L
    New Hope For People With Dysglycemia and Cardiovascular Disease Manifestations: Reduction of Acute Coronary Events With Pioglitazone.
    Circulation. 2017;135:1894-1896.
    >> Share

  143. DALE C, Fatemifar G, Palmer T, White J, et al
    Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis.
    Circulation. 2017 May 12. pii: CIRCULATIONAHA.116.026560.
    >> Share

  144. KESSLER T, Wobst J, Wolf B, Eckhold J, et al
    Functional Characterization of the GUCY1A3 Coronary Artery Disease Risk Locus.
    Circulation. 2017 May 9. pii: CIRCULATIONAHA.116.024152.
    >> Share

  145. PURI R, Puri S, Rajani A
    Letter by Puri et al Regarding Article, "Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control".
    Circulation. 2017;135:e1039-e1040.
    >> Share

  146. WEINTRAUB WS, Garratt KN
    Public Reporting II: State of the Art-Current Public Reporting in Cardiovascular Medicine.
    Circulation. 2017;135:1772-1774.
    >> Share

  147. ZANNAD F, Rossignol P
    Cardiovascular Outcome Trials in Patients With Advanced Kidney Disease: Time for Action.
    Circulation. 2017;135:1769-1771.
    >> Share

  148. GOLDBERG RB, Aroda VR, Bluemke DA, Barrett-Connor E, et al
    Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium.
    Circulation. 2017 May 5. pii: CIRCULATIONAHA.116.025483.
    >> Share

  149. WADHERA P, Alexander T, Nallamothu BK
    India and the Coronary Stent Market: Getting the Price Right.
    Circulation. 2017 May 4. pii: CIRCULATIONAHA.117.028191.
    >> Share

  150. WADHERA RK, Joynt KE
    Insurance and Cardiovascular Health: Time for Evidence to Trump Politics.
    Circulation. 2017 May 4. pii: CIRCULATIONAHA.117.028618.
    >> Share

  151. SMOLDEREN KG, Spertus JA, Gosch K, Dreyer RP, et al
    Depression Treatment and Health Status Outcomes in Young Patients With Acute Myocardial Infarction: Insights From the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients).
    Circulation. 2017;135:1762-1764.
    >> Share

  152. DAVIDSON KW
    Waiting for Godot: Engaging in Discussions About Depression Care in Patients With Acute Myocardial Infarction While Waiting for a Definitive Trial That Never Appears.
    Circulation. 2017;135:1690-1692.
    >> Share

  153. MERGHANI A, Maestrini V, Rosmini S, Cox AT, et al
    Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes with a Low Atherosclerotic Risk Profile.
    Circulation. 2017 May 2. pii: CIRCULATIONAHA.116.026964.
    >> Share

  154. SAITO Y, Ogawa H, Morimoto T
    Response by Saito et al to Letter Regarding Article, "Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial".
    Circulation. 2017;135:e1010-e1011.
    >> Share

  155. AHMED SB, Metcalfe A, Nerenberg K
    Letter by Ahmed et al Regarding Article, "Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial".
    Circulation. 2017;135:e1008-e1009.
    >> Share

  156. NASIR K, Keeley B, Krumholz HM
    Living Longer in Good Cardiovascular Health: Prevention and Wellness Makes Economic Cents.
    Circulation. 2017;135:1702-1704.
    >> Share

  157. ALLEN NB, Zhao L, Liu L, Daviglus M, et al
    Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry).
    Circulation. 2017;135:1693-1701.
    >> Share

  158. VAN DE WERF F
    Prevention of Cardiovascular Events in Patients With Diabetes: How Beneficial Is Dual Antiplatelet Therapy?
    Circulation. 2017;135:1675-1676.
    >> Share

    April 2017
  159. KHERA AV, Demler O, Adelman SJ, Collins HL, et al
    Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events. An Analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Circulation. 2017 Apr 27. pii: CIRCULATIONAHA.116.025678.
    >> Share

  160. AENGEVAEREN VL, Mosterd A, Braber TL, Prakken NHJ, et al
    The Relationship Between Lifelong Exercise Volume and Coronary Atherosclerosis in Athletes.
    Circulation. 2017 Apr 27. pii: CIRCULATIONAHA.117.027834.
    >> Share

  161. KNOWLES JW, Howard WB, Karayan L, Baum SJ, et al
    Access to Non-Statin Lipid Lowering Therapies in Patients at High-Risk of Atherosclerotic Cardiovascular Disease.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.027705.
    >> Share

  162. BHINDI R, Banning AP
    Not So Fast: Complete Revascularization of the ST-Segment-Elevation Myocardial Infarction Patient Is Not Yet Proven.
    Circulation. 2017;135:1574-1576.
    >> Share

  163. OLDROYD KG
    Complete Immediate Revascularization of the Patient With ST-Segment-Elevation Myocardial Infarction Is the New Standard of Care.
    Circulation. 2017;135:1571-1573.
    >> Share

  164. SMITH JG, Gerszten RE
    Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Circulation. 2017;135:1651-1664.
    >> Share

  165. BORG N, Alter C, Gorldt N, Jacoby C, et al
    CD73 on T-Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
    Circulation. 2017 Apr 21. pii: CIRCULATIONAHA.116.023365.
    >> Share

  166. THAN MP, Pickering JW, Cullen L, Kavsak PA, et al
    Response by Than et al to Letter Regarding Article, "Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction".
    Circulation. 2017;135:e923-e924.
    >> Share

  167. MUELLER C, Roffi M
    Letter by Mueller and Roffi Regarding Article, "Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction".
    Circulation. 2017;135:e921-e922.
    >> Share

  168. IRFAN A
    Letter by Irfan Regarding Article, "Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction".
    Circulation. 2017;135:e919-e920.
    >> Share

  169. PASUPATHY S, Tavella R, Beltrame JF
    Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): The Past, Present, and Future Management.
    Circulation. 2017;135:1490-1493.
    >> Share

  170. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Circulation. 2017;135:1522-1531.
    >> Share

  171. HERNANDEZ AF, Cruz HP
    Engagement, Research, and Evidence: Leveraging the National Patient-Centered Clinical Research Network for Better Cardiovascular Health.
    Circulation. 2017;135:1478-1480.
    >> Share

  172. MOTOVSKA Z, Hlinomaz O, Kala P
    Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study".
    Circulation. 2017;135:e887-e888.
    >> Share

  173. LOZANO I, Rondan J, Vegas JM
    Letter by Lozano et al Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study".
    Circulation. 2017;135:e885-e886.
    >> Share

  174. KUBOTA Y, Iso H, Yamagishi K, Sawada N, et al
    Daily Total Physical Activity and Incident Cardiovascular Disease in Japanese Men and Women: Japan Public Health Center-Based Prospective Study.
    Circulation. 2017;135:1471-1473.
    >> Share

  175. BASS TA
    Percutaneous Coronary Interventions for Chronic Total Occlusions: As the Technology Expands, Our Responsibilities Increase.
    Circulation. 2017;135:1385-1387.
    >> Share

  176. HOFFMANN U, Ferencik M, Udelson JE, Picard MH, et al
    Prognostic Value of Noninvasive Cardiovascular Testing in Patients with Stable Chest Pain: Insights from the PROMISE Trial.
    Circulation. 2017 Apr 7. pii: CIRCULATIONAHA.116.024360.
    >> Share

  177. HUNTER AL, Shah AS, Langrish JP, Raftis JB, et al
    Fire Simulation and Cardiovascular Health in Firefighters.
    Circulation. 2017;135:1284-1295.
    >> Share

  178. AMERI K, Samurkashian R, Yeghiazarians Y
    Three-Dimensional Bioprinting: Emerging Technology in Cardiovascular Medicine.
    Circulation. 2017;135:1281-1283.
    >> Share

    March 2017
  179. DE LEMOS JA, Ayers CR, Levine BD, deFilippi CR, et al
    A Multimodality Strategy for Cardiovascular Risk Assessment: Performance in Two Population-Based Cohorts.
    Circulation. 2017 Mar 30. pii: CIRCULATIONAHA.117.027272.
    >> Share

  180. AHN JM, Park DW, Shin ES, Koo BK, et al
    Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective Registry.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.024433.
    >> Share

  181. DAVIERWALA PM, Leontyev S
    Response by Davierwala and Leontyev to Letter Regarding Article, "Temporal Trends in Predictors of Early and Late Mortality after Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction".
    Circulation. 2017;135:e816-e817.
    >> Share

  182. KALAVROUZIOTIS D, Dagenais F, Mohammadi S
    Letter by Kalavrouziotis et al Regarding Article, "Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction".
    Circulation. 2017;135:e814-e815.
    >> Share


  183. Correction to: Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American C
    Circulation. 2017;135:e824-e825.
    >> Share

  184. YANG X, Gu D
    Response by Yang and Gu to Letter Regarding Article, "Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)".
    Circulation. 2017;135:e822-e823.
    >> Share

  185. KOH KK
    Letter by Koh Regarding Articles, "Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)" and "Distribution of Estimated 10-Year Risk of Recurrent Vascu
    Circulation. 2017;135:e818-e819.
    >> Share

  186. FORMAN DE, Arena R, Boxer R, Dolansky MA, et al
    Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association.
    Circulation. 2017 Mar 23. pii: CIR.0000000000000483.
    >> Share


  187. Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2017;135:e789.
    >> Share


  188. Correction to: Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Circulation. 2017;135:e788.
    >> Share

  189. YEH RW, Kramer DB
    Decision Tools to Improve Personalized Care in Cardiovascular Disease: Moving the Art of Medicine Toward Science.
    Circulation. 2017;135:1097-1100.
    >> Share

  190. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
    Circulation. 2017;135:1123-1132.
    >> Share

  191. BAIREY MERZ CN, Pepine CJ, Walsh MN, Fleg JL, et al
    Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.
    Circulation. 2017;135:1075-1092.
    >> Share

  192. TANG WH, Hazen SL
    The Gut Microbiome and Its Role in Cardiovascular Diseases.
    Circulation. 2017;135:1008-1010.
    >> Share

  193. KHERA AV, Kathiresan S
    Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine.
    Circulation. 2017;135:1005-1007.
    >> Share

  194. GAUDINO M, Puskas JD, Di Franco A, Ohmes LB, et al
    Three Arterial Grafts Improve Late Survival: A Meta-Analysis of Propensity-Matched Studies.
    Circulation. 2017;135:1036-1044.
    >> Share

  195. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    >> Share

  196. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Wildi K, et al
    Direct Comparison of Four Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I.
    Circulation. 2017 Mar 10. pii: CIRCULATIONAHA.116.025661.
    >> Share

  197. WANG DD, Toledo E, Hruby A, Rosner BA, et al
    Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial.
    Circulation. 2017 Mar 9. pii: CIRCULATIONAHA.116.024261.
    >> Share

  198. PEREZ DE ISLA L, Alonso R, Mata N, Fernandez-Perez C, et al
    Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry.
    Circulation. 2017 Mar 8. pii: CIRCULATIONAHA.116.024541.
    >> Share

  199. SMYTH A, O'Donnell M, Yusuf S
    Response by Smyth et al to Letters Regarding Article, "Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study".
    Circulation. 2017;135:e644-e645.
    >> Share

  200. SCHERFF F, Ghadri J, Templin C
    Letter by Scherff et al Regarding Article, "Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study".
    Circulation. 2017;135:e642-e643.
    >> Share

  201. CULIC V
    Letter by Culic Regarding Article, "Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study".
    Circulation. 2017;135:e640-e641.
    >> Share

  202. FIDLER MM, Reulen RC, Henson K, Kelly J, et al
    Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.
    Circulation. 2017;135:951-963.
    >> Share

  203. MOHAMED TM, Stone NR, Berry EC, Radzinsky E, et al
    Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.
    Circulation. 2017;135:978-995.
    >> Share

  204. MADDOX TM, Albert NM, Borden WB, Curtis LH, et al
    The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Mar 2. pii: CIR.0000000000000480.
    >> Share

  205. WALDO SW, McCabe JM, Kennedy KF, Zigler CM, et al
    Quality of Care at Hospitals Identified as Outliers in Publicly Reported Mortality Statistics for Percutaneous Coronary Intervention.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.025998.
    >> Share

    February 2017
  206. CAVENDER MA, White WB, Jarolim P, Bakris GL, et al
    Serial Measurement of High Sensitivity Troponin I and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus in the EXAMINE Trial.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024632.
    >> Share

  207. MENEVEAU N, Ecarnot F
    Response by Meneveau and Ecarnot to Letter Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOC
    Circulation. 2017;135:e142-e143.
    >> Share

  208. VALLURUPALLI S, Uretsky BF
    Letter by Vallurupalli and Uretsky Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Stu
    Circulation. 2017;135:e140-e141.
    >> Share

  209. NADIR MA
    Letter by Nadir Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Co
    Circulation. 2017;135:e138-e139.
    >> Share

  210. GERSH BJ, Stone GW, Bhatt DL
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery Disease: Do We Have the Evidence?
    Circulation. 2017;135:819-821.
    >> Share

  211. YOUNG LH, Viscoli CM, Curtis JP, Inzucchi SE, et al
    Cardiac Outcomes After Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance Without Diabetes.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024863.
    >> Share

  212. STEFANESCU SCHMIDT AC, Kereiakes DJ, Cutlip DE, Yeh RW, et al
    Myocardial Infarction Risk after Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study.
    Circulation. 2017 Feb 22. pii: CIRCULATIONAHA.116.024835.
    >> Share

  213. SMOLDEREN KG, Buchanan DM, Gosch K, Whooley MA, et al
    Depression Treatment and 1-Year Mortality Following Acute Myocardial Infarction: Insights from the TRIUMPH Registry.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.025140.
    >> Share

  214. ATKINSON TM, Giraud GD, Togioka BM, Jones DB, et al
    Cardiovascular and Ventilatory Consequences of Laparoscopic Surgery.
    Circulation. 2017;135:700-710.
    >> Share

  215. HERNAEZ A, Castaner O, Elosua R, Pinto X, et al
    Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial.
    Circulation. 2017;135:633-643.
    >> Share

  216. LINDAHL B, Baron T, Erlinge D, Hadziosmanovic N, et al
    Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients with Myocardial Infarction with Non-Obstructive Coronary Artery (MINOCA) Disease.
    Circulation. 2017 Feb 8. pii: CIRCULATIONAHA.116.026336.
    >> Share

  217. CHOO EH, Lee JH, Park EH, Park HE, et al
    Infarcted Myocardium-Primed Dendritic Cells Improve Remodeling and Cardiac Function After Myocardial Infarction by Modulating the Treg and Macrophage Polarization.
    Circulation. 2017 Feb 7. pii: CIRCULATIONAHA.116.023106.
    >> Share

  218. HESS CN, Kaltenbach LA, Doll JA, Cohen DJ, et al
    Race and Sex Differences in Post-Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization.
    Circulation. 2017;135:532-543.
    >> Share

  219. DREYER RP, Dharmarajan K, Kennedy KF, Jones PG, et al
    Sex Differences in 1-Year All-Cause Rehospitalization in Patients After Acute Myocardial Infarction: A Prospective Observational Study.
    Circulation. 2017;135:521-531.
    >> Share

  220. RAMIREZ FD, Motazedian P, Jung RG, Di Santo P, et al
    Sex Bias Is Increasingly Prevalent in Preclinical Cardiovascular Research: Implications for Translational Medicine and Health Equity for Women: A Systematic Assessment of Leading Cardiovascular Journals Over a 10-Year Period.
    Circulation. 2017;135:625-626.
    >> Share

  221. SANGHAVI M, Parikh NI
    Harnessing the Power of Pregnancy and Pregnancy-Related Events to Predict Cardiovascular Disease in Women.
    Circulation. 2017;135:590-592.
    >> Share

  222. TANZ LJ, Stuart JJ, Williams PL, Rimm EB, et al
    Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women.
    Circulation. 2017;135:578-589.
    >> Share

  223. DE KAT AC, Verschuren WM, Eijkemans MJ, Broekmans FJ, et al
    Anti-Mullerian Hormone Trajectories Are Associated With Cardiovascular Disease in Women: Results From the Doetinchem Cohort Study.
    Circulation. 2017;135:556-565.
    >> Share

  224. PATEL A, Rutherford JD
    Improving Cardiovascular Health in Diverse Populations: A Conversation With Anushka Patel, MBBS, SM, PhD.
    Circulation. 2017;135:502-505.
    >> Share

  225. POLONSKY TS, Greenland P
    Breast Arterial Calcification: Expanding the Reach of Cardiovascular Prevention.
    Circulation. 2017;135:499-501.
    >> Share

  226. GULATI M
    Improving the Cardiovascular Health of Women in the Nation: Moving Beyond the Bikini Boundaries.
    Circulation. 2017;135:495-498.
    >> Share

  227. HAO H, Hu S, Chen H, Bu D, et al
    Loss of Endothelial CXCR7 Impairs Vascular Homeostasis, and Cardiac Remodeling After Myocardial Infarction: Implications for Cardiovascular Drug Discovery.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.023027.
    >> Share

  228. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    >> Share

    January 2017
  229. PARIKH VN, Ashley EA
    Next-Generation Sequencing in Cardiovascular Disease: Present Clinical Applications and the Horizon of Precision Medicine.
    Circulation. 2017;135:406-409.
    >> Share

  230. MADDOX TM, Ho PM
    Health Services Research in Improving the Delivery of Care for Patients with Cardiovascular Diseases: Moving From Observation to Innovation to Action.
    Circulation. 2017;135:403-405.
    >> Share

  231. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    >> Share

  232. ST-ONGE MP, Ard J, Baskin ML, Chiuve SE, et al
    Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Jan 30. pii: CIR.0000000000000476.
    >> Share

  233. ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
    Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
    Circulation. 2017;135:400-402.
    >> Share

  234. HEYDARI B, Harris WS, Kwong RY
    Response by Heydari et al to Letter Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Circulation. 2017;135:e13-e14.
    >> Share

  235. NAGELE MP
    Letter by Nagele Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Circulation. 2017;135:e11-e12.
    >> Share

  236. KOH KK
    Letter by Koh Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Circulation. 2017;135:e9-e10.
    >> Share

  237. KRISTENSEN SL, Mogensen UM, Jhund PS, Petrie MC, et al
    Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Tria
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.024593.
    >> Share

  238. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    >> Share

  239. ALEXANDER KP
    Putting the Acute Coronary Syndrome in Context After 80 Years of Age.
    Circulation. 2017;135:5-6.
    >> Share

  240. SHI G, Zhu Z, Chen J, Ou Y, et al
    Total Anomalous Pulmonary Venous Connection: The Current Management Strategies in a Pediatric Cohort of 768 Patients.
    Circulation. 2017;135:48-58.
    >> Share

  241. ZANGI L, Oliveira MS, Ye LY, Ma Q, et al
    Insulin-Like Growth Factor 1 Receptor-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury.
    Circulation. 2017;135:59-72.
    >> Share

    December 2016
  242. CHAPMAN AR, Anand A, Boeddinghaus J, Ferry AV, et al
    Comparison of the Efficacy and Safety of Early Rule Out Pathways for Acute Myocardial Infarction.
    Circulation. 2016 Dec 29. pii: CIRCULATIONAHA.116.025021.
    >> Share

  243. SCHWAMM LH, Chumbler N, Brown E, Fonarow GC, et al
    Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
    Circulation. 2016 Dec 20. pii: CIR.0000000000000475.
    >> Share

  244. STEBLOVNIK K, Blinc A, Mijovski MB, Fister M, et al
    Ticagrelor Versus Clopidogrel in Comatose Survivors of Out-of-Hospital Cardiac Arrest Undergoing Percutaneous Coronary Intervention and Hypothermia: A Randomized Study.
    Circulation. 2016;134:2128-2130.
    >> Share

  245. WO D, Peng J, Ren DN, Qiu L, et al
    Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and beta-catenin.
    Circulation. 2016;134:1991-2007.
    >> Share

  246. JOLLY SS, James SK, Dzavik V, Cairns JA, et al
    Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
    Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
    >> Share

  247. KOH KK
    Letter by Koh Regarding Article, "Randomized Trials to Evaluate Cardiovascular Safety of Antihyperglycemic Medications: A Worthwhile Effort?"
    Circulation. 2016;134:e650-e651.
    >> Share

  248. WILSON PW, Pencina MJ
    Estimation of Risk for Initial Atherosclerotic Cardiovascular Disease Events: Taking Stock and Moving Forward.
    Circulation. 2016;134:1792-1793.
    >> Share

  249. GARGIULO G, Windecker S, Vranckx P, Gibson CM, et al
    A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?
    Circulation. 2016;134:1881-1906.
    >> Share

    November 2016
  250. VILAHUR G, Gutierrez M, Casani L, Varela L, et al
    Protective Effects of Ticagrelor on Myocardial Injury After Infarction.
    Circulation. 2016;134:1708-1719.
    >> Share

  251. MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
    Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
    >> Share

  252. HOUSER SR
    The American Heart Association's New Institute for Precision Cardiovascular Medicine.
    Circulation. 2016 Nov 22. pii: CIRCULATIONAHA.116.022138.
    >> Share

  253. HAMPTON T
    Ongoing Research Points to Key Role of Gut Microbes in Cardiovascular Health.
    Circulation. 2016;134:1687-1688.
    >> Share

  254. DIPROSE W, Verster F
    The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality.
    Circulation. 2016;134:1599-1600.
    >> Share

  255. GAGGIN HK, Liu Y, Lyass A, van Kimmenade RR, et al
    Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.023052.
    >> Share

  256. POKORNEY SD, Miller AL, Chen AY, Thomas L, et al
    Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients with Low Ejection Fraction After Myocardial Infarction.
    Circulation. 2016 Nov 16. pii: CIRCULATIONAHA.116.022359.
    >> Share

  257. GIBSON CM, Korjian S, Tricoci P, Daaboul Y, et al
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
    Circulation. 2016 Nov 15. pii: CIRCULATIONAHA.116.025687.
    >> Share

  258. SHEN YC, Hsia RY
    Association Between Emergency Department Closure and Treatment, Access, and Health Outcomes Among Patients With Acute Myocardial Infarction.
    Circulation. 2016;134:1595-1597.
    >> Share

  259. SAITO Y, Okada S, Ogawa H, Soejima H, et al
    Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial.
    Circulation. 2016 Nov 15. pii: CIRCULATIONAHA.116.025760.
    >> Share

  260. TOPPER JN, Rutherford JD
    Discovering and Developing Successful Cardiovascular Therapeutics: A Conversation With James N. Topper, MD, PhD.
    Circulation. 2016;134:1516-1518.
    >> Share

  261. TAQUETI VR, Shaw LJ, Cook NR, Murthy VL, et al
    Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography is Associated with Severely Impaired Coronary Flow Reserve, not Obstructive Disease.
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.023266.
    >> Share

  262. GIBSON CM, Pinto DS, Chi G, Arbetter D, et al
    Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025783.
    >> Share

  263. LEE SR, Prasad A, Choi YS, Xing C, et al
    The LPA Gene, Ethnicity, and Cardiovascular Events.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024611.
    >> Share

  264. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    >> Share

  265. BAR C, Chatterjee S, Thum T
    Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy.
    Circulation. 2016;134:1484-1499.
    >> Share

  266. ABBAS M, Jesel L, Auger C, Amoura LK, et al
    Endothelial Microparticles from Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cells Ageing and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-mediated Activation of MAPKs and PI3-kinase Pathways.
    Circulation. 2016 Nov 7. pii: CIRCULATIONAHA.116.017513.
    >> Share

  267. LYNGBAKKEN MN, Skranes JB, de Lemos JA, Nygard S, et al
    Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023726.
    >> Share

  268. LLOYD-JONES DM, Huffman MD, Karmali KN, Sanghavi DM, et al
    Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardi
    Circulation. 2016 Nov 4. pii: CIR.0000000000000467.
    >> Share

  269. CARRICK D, Haig C, Ahmed N, Carberry J, et al
    Comparative Prognostic Utility of Indices of Microvascular Function Alone or in Combination in Patients with an Acute ST-Segment Elevation Myocardial Infarction.
    Circulation. 2016 Nov 1. pii: CIRCULATIONAHA.116.022603.
    >> Share

  270. BLOND K, Jensen MK, Rasmussen MG, Overvad K, et al
    Prospective Study of Bicycling and Risk of Coronary Heart Disease in Danish Men and Women.
    Circulation. 2016;134:1409-1411.
    >> Share

  271. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Response by Alvarez-Garcia et al to Letters Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e401-e402.
    >> Share

  272. BARANCHUK A
    Letter by Baranchuk Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e399-e400.
    >> Share

  273. NG FS, Efimov IR
    Letter by Ng and Efimov Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e397-e398.
    >> Share

  274. MCKELLAR SH, Fang JC
    An Age-Old Question: What Is Too Old for Coronary Artery Bypass Grafting in Heart Failure?
    Circulation. 2016;134:1325-1327.
    >> Share

    October 2016
  275. KARAM N, Bataille S, Marijon E, Giovanetti O, et al
    Identifying Patients at Risk for Pre-Hospital Sudden Cardiac Arrest at the Early Phase of Myocardial Infarction: The e-MUST Study.
    Circulation. 2016 Oct 28. pii: CIRCULATIONAHA.116.022954.
    >> Share

  276. DAVIERWALA PM, Leontyev S, Verevkin A, Rastan AJ, et al
    Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction.
    Circulation. 2016;134:1224-1237.
    >> Share

  277. KURLANSKY P, Herbert M, Prince S, Mack M, et al
    Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative Outcomes.
    Circulation. 2016;134:1238-1246.
    >> Share

  278. KIRMANI BH, Holmes MV, Muir AD
    Long-Term Survival and Freedom From Reintervention After Off-Pump Coronary Artery Bypass Grafting: A Propensity-Matched Study.
    Circulation. 2016;134:1209-1220.
    >> Share

  279. GLINEUR D, Gaudino M, Grau J
    The Evolution of Coronary Bypass Surgery Will Determine Its Relevance as the Standard of Care for the Treatment for Multivessel Coronary Artery Disease.
    Circulation. 2016;134:1206-1208.
    >> Share

  280. RUEL M
    Introduction to the Cardiovascular Surgery Themed Issue of Circulation.
    Circulation. 2016;134:1205.
    >> Share

  281. CAPOULADE R, Zeng X, Overbey JR, Ailawadi G, et al
    Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.
    Circulation. 2016;134:1247-1256.
    >> Share

  282. RAY KK, Ginsberg HN, Davidson MH, Pordy R, et al
    Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab to Control.
    Circulation. 2016 Oct 24. pii: CIRCULATIONAHA.116.024604.
    >> Share

  283. FRIEDMAN DJ, Bao H, Spatz ES, Curtis JP, et al
    Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report from the National Cardiovascular Data Registry.
    Circulation. 2016 Oct 19. pii: CIRCULATIONAHA.116.022913.
    >> Share

  284. ALSHEHRY ZH, Mundra PA, Barlow CK, Mellett NA, et al
    Plasma Lipidomic Profiles Improve Upon Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.023233.
    >> Share

  285. PECHLANER R, Kiechl S, Mayr M
    Potential and Caveats of Lipidomics for Cardiovascular Disease.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.025092.
    >> Share

  286. SYME C, Czajkowski S, Shin J, Abrahamowicz M, et al
    Glycerophosphocholine Metabolites and Cardiovascular Disease Risk Factors in Adolescents: A Cohort Study.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.022993.
    >> Share


  287. Correction to: Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e366.
    >> Share

  288. BOHM P, Kindermann W, Meyer T, Scharhag J, et al
    Response by Bohm et al to Letter Regarding Article, "Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study".
    Circulation. 2016;134:e364-e365.
    >> Share

  289. LEISCHIK R, Sanchis-Gomar F, Lucia A
    Letter by Leischik et al Regarding Article, "Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study".
    Circulation. 2016;134:e362-e363.
    >> Share

  290. HEIDBUCHEL H, Claessen G, La Gerche A
    Letter by Heidbuchel et al Regarding Article, "Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study".
    Circulation. 2016;134:e360-e361.
    >> Share

  291. PICKERING JW, Greenslade JH, Cullen L, Flaws D, et al
    Assessment of the European Society of Cardiology 0 Hour/1 Hour Algorithm to Rule Out and Rule In Acute Myocardial Infarction.
    Circulation. 2016 Oct 17. pii: CIRCULATIONAHA.116.022677.
    >> Share

  292. JAFFE AS, White HD
    Ruling In Myocardial Injury and Ruling Out Myocardial Infarction With the European Society of Cardiology (ESC) 1-Hour Algorithm.
    Circulation. 2016 Oct 17. pii: CIRCULATIONAHA.116.024687.
    >> Share

  293. WIGGINS BS, Saseen JJ, Page RL 2nd, Reed BN, et al
    Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 17. pii: CIR.0000000000000456.
    >> Share

  294. CAPODANNO D, Angiolillo DJ
    Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus.
    Circulation. 2016 Oct 11. pii: CIRCULATIONAHA.116.023164.
    >> Share

  295. SMYTH A, O'Donnell M, Lamelas P, Teo K, et al
    Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study.
    Circulation. 2016;134:1059-1067.
    >> Share

  296. BAGAI A, Bhatt DL, Verma S, Mehta SR, et al
    Response by Bagai et al to Letter Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention".
    Circulation. 2016;134:e334-e335.
    >> Share

  297. PETRIE CJ
    Letter by Petrie Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention".
    Circulation. 2016;134:e332-e333.
    >> Share

  298. WIRTZ VJ, Kaplan WA, Kwan GF, Laing RO, et al
    Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries".
    Circulation. 2016;134:e305-e306.
    >> Share

  299. ANTIGNAC M, Marijon E, Jouven X
    Letter by Antignac et al Regarding Article "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries".
    Circulation. 2016;134:e303-e304.
    >> Share

  300. HAMPTON T
    Energy Drinks Pose Worrisome Risks to Adolescents' Cardiovascular Health.
    Circulation. 2016;134:1052-1053.
    >> Share

  301. RESOR CD, Nathan A, Kereiakes DJ, Yeh RW, et al
    Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
    Circulation. 2016;134:989-998.
    >> Share

    September 2016
  302. SEIDELMANN SB, Claggett B, Bravo PE, Gupta A, et al
    Retinal Vessel Calibers in Predicting Long-term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.023425.
    >> Share

  303. YANG X, Li J, Hu D, Chen J, et al
    Predicting the Ten-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.022367.
    >> Share

  304. KAASENBROOD L, Boekholdt SM, van der Graaf Y, Ray KK, et al
    Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.021314.
    >> Share

  305. KOH KK
    Letter by Koh Regarding Article, "Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: 16 Years of Follow-Up of the LIPID Study".
    Circulation. 2016;134:e294-5.
    >> Share

  306. VAN DEN BERG VJ, Umans VA, Stam F, de Mulder M, et al
    Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.
    Circulation. 2016;134:984-6.
    >> Share


  307. Correction to: Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension.
    Circulation. 2016;134:e260.
    >> Share

  308. LU MT, Onuma OK, Massaro JM, D'Agostino RB Sr, et al
    Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events.
    Circulation. 2016;134:897-9.
    >> Share

  309. MANGIACAPRA F, Panaioli E, Colaiori I, Ricottini E, et al
    Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)
    Circulation. 2016;134:835-7.
    >> Share

  310. HAMPTON T
    Experts Ponder Whether Too Much Exercise Can Compromise Cardiovascular Health and Longevity.
    Circulation. 2016;134:833-4.
    >> Share

  311. STOREY RF, Parker WA
    Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus.
    Circulation. 2016;134:793-6.
    >> Share

  312. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    >> Share

  313. RAGHUVEER G, White DA, Hayman LL, Woo JG, et al
    Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Sep 12. pii: CIR.0000000000000443.
    >> Share

  314. OPARIL S, Lewis CE
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to < 120/80 mmHg Target?: A Protagonist View from SPRINT.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023263.
    >> Share


  315. Correction to: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideline
    Circulation. 2016;134:e192-4.
    >> Share

  316. HIVERT MF, Arena R, Forman DE, Kris-Etherton PM, et al
    Medical Training to Achieve Competency in Lifestyle Counseling: An Essential Foundation for Prevention and Treatment of Cardiovascular Diseases and Other Chronic Medical Conditions: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Sep 6. pii: CIR.0000000000000442.
    >> Share


  317. Correction to: Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/A
    Circulation. 2016;134:e195-7.
    >> Share

  318. EVERETT BM, Hiatt WR
    Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death.
    Circulation. 2016;134:773-5.
    >> Share

    August 2016
  319. MOTOVSKA Z, Hlinomaz O, Miklik R, Hromadka M, et al
    Prasugrel versus Ticagrelor in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024823.
    >> Share

  320. BONACA MP, Goto S, Bhatt DL, Steg PG, et al
    Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-T
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024637.
    >> Share


  321. Correction to: Part 10: Special Circumstances of Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2016;134:e122.
    >> Share


  322. Correction to: Part 6: Pediatric Basic Life Support and Pediatric Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2016;134:e121.
    >> Share

  323. LEMPERT LK, Yerger V, Glantz SA
    Letter by Lempert et al Regarding Article, "Menthol and Nonmenthol Cigarette Smoking: All-Cause Deaths, Cardiovascular Disease Deaths, and Other Causes of Death Among Blacks and Whites".
    Circulation. 2016;134:e119-20.
    >> Share

  324. MOUNSEY CA, Mawhinney JA, Werner RS, Taggart DP, et al
    Does Previous Transradial Catheterization Preclude Use of the Radial Artery as a Conduit in Coronary Artery Bypass Surgery?
    Circulation. 2016;134:681-8.
    >> Share

  325. MASOUDI FA
    Quality Measurement and Accountability in Cardiovascular Medicine: An Incomplete Revolution.
    Circulation. 2016;134:632-4.
    >> Share

  326. SABE MA, Sabe SA, Kusunose K, Flamm SD, et al
    Predictors and Prognostic Significance of Right Ventricular Ejection Fraction in Patients With Ischemic Cardiomyopathy.
    Circulation. 2016;134:656-65.
    >> Share

  327. PETRIE MC, Jhund PS, She L, Adlbrecht C, et al
    Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure)
    Circulation. 2016 Aug 29. pii: CIRCULATIONAHA.116.024800.
    >> Share

  328. MENEVEAU N, Souteyrand G, Motreff P, Caussin C, et al
    Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS (Does Optical Coherence Tomography Optimize Results of Ste
    Circulation. 2016 Aug 29. pii: CIRCULATIONAHA.116.024393.
    >> Share

  329. FRANCHI F, Rollini F, Aggarwal N, Hu J, et al
    A Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
    Circulation. 2016 Aug 24. pii: CIRCULATIONAHA.116.023402.
    >> Share

  330. NORBY FL, Soliman EZ, Chen LY, Bengtson LG, et al
    Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).
    Circulation. 2016;134:599-610.
    >> Share

  331. STEG PG, Roussel R
    Randomized Trials to Evaluate Cardiovascular Safety of Antihyperglycemic Medications: A Worthwhile Effort?
    Circulation. 2016;134:571-3.
    >> Share

  332. SHARKEY SW, Orlandi Q, Olivari MT
    Response by Sharkey et al to Letter Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e111-2.
    >> Share

  333. LITTMANN L
    Letter by Littmann Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e109-10.
    >> Share

  334. ROSSELLO X, Yellon DM
    Cardioprotection: The Disconnect Between Bench and Bedside.
    Circulation. 2016;134:574-5.
    >> Share

  335. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    >> Share

  336. BRAILLON A
    Letter by Braillon Regarding Article, "Resource Effective Strategies to Prevent and Treat Cardiovascular Disease".
    Circulation. 2016;134:e85-6.
    >> Share

  337. HOLLANDER JE, Than M, Mueller C
    State-of-the-Art Evaluation of Emergency Department Patients Presenting With Potential Acute Coronary Syndromes.
    Circulation. 2016;134:547-64.
    >> Share

  338. WING JJ, August E, Adar SD, Dannenberg AL, et al
    Change in Neighborhood Characteristics and Change in Coronary Artery Calcium: A Longitudinal Investigation in the MESA (Multi-Ethnic Study of Atherosclerosis) Cohort.
    Circulation. 2016;134:504-13.
    >> Share

  339. CALIFF RM
    The US Food and Drug Administration and Cardiovascular Medicine: Reflections and Observations.
    Circulation. 2016;134:501-3.
    >> Share

  340. KUEHN BM
    US Cardiologists Embrace Population Health.
    Circulation. 2016;134:565-6.
    >> Share

  341. YOUNG DR, Hivert MF, Alhassan S, Camhi SM, et al
    Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association.
    Circulation. 2016 Aug 15. pii: CIR.0000000000000440.
    >> Share

  342. STEINBERGER J, Daniels SR, Hagberg N, Isasi CR, et al
    Cardiovascular Health Promotion in Children: Challenges and Opportunities for 2020 and Beyond: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 11. pii: CIR.0000000000000441.
    >> Share

  343. BRAUN LT, Grady KL, Kutner JS, Adler E, et al
    Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association.
    Circulation. 2016 Aug 8. pii: CIR.0000000000000438.
    >> Share

  344. HEYDARI B, Abdullah S, Pottala JV, Shah R, et al
    Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
    Circulation. 2016;134:378-91.
    >> Share

  345. JACOBS AK
    The Challenge to Implement Systems of Care for ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2016;134:375-7.
    >> Share

  346. KIRTANE AJ, Doshi D, Leon MB, Lasala JM, et al
    Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.
    Circulation. 2016;134:422-31.
    >> Share

  347. JOLLIS JG, Al-Khalidi HR, Roettig ML, Berger PB, et al
    Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator.
    Circulation. 2016;134:365-74.
    >> Share

  348. DOUGLAS PS
    Achieving the Full "PROMISE" of Imaging Outcomes Research.
    Circulation. 2016;134:359-61.
    >> Share

  349. CAVENDER MA, Bhatt DL, Stone GW, White HD, et al
    Consistent Reduction in Peri-Procedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX.
    Circulation. 2016 Aug 1. pii: CIRCULATIONAHA.115.020829.
    >> Share

    July 2016
  350. HEERSPINK HJ, Perkins BA, Fitchett DH, Husain M, et al
    Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes: Cardiovascular and Kidney Effects, Potential Mechanisms and Clinical Applications.
    Circulation. 2016 Jul 28. pii: CIRCULATIONAHA.116.021887.
    >> Share

  351. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    >> Share

  352. BOHULA EA, Bonaca MP, Braunwald E, Aylward PE, et al
    Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
    Circulation. 2016;134:304-13.
    >> Share

  353. NANCHEN D, Gencer B, Muller O, Auer R, et al
    Prognosis of Patients with Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.116.023007.
    >> Share

  354. NGO D, Sinha S, Shen D, Kuhn EW, et al
    Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Circulation. 2016;134:270-85.
    >> Share

  355. GRAMOLINI A, Lau E, Liu PP
    Identifying Low-Abundance Biomarkers: Aptamer-Based Proteomics Potentially Enables More Sensitive Detection in Cardiovascular Diseases.
    Circulation. 2016;134:286-9.
    >> Share

  356. TANG SY, Monslow J, R Grant G, Todd L, et al
    Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
    Circulation. 2016;134:328-38.
    >> Share

  357. MICHOS ED, Blaha MJ
    Encouraging Young Women to Move More: Linking Physical Activity in Young Adulthood to Coronary Risk in Women.
    Circulation. 2016;134:300-3.
    >> Share

  358. ANTER E, Tschabrunn CM, Buxton AE, Josephson ME, et al
    High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit.
    Circulation. 2016;134:314-27.
    >> Share

  359. BITTENCOURT MS, Hulten E, Polonsky TS, Hoffman U, et al
    European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry.
    Circulation. 2016;134:201-11.
    >> Share

  360. DZAU VJ
    The National Academy of Medicine and the Cardiovascular Community: Partnering for a Healthier Future.
    Circulation. 2016;134:183-5.
    >> Share

  361. ROGERS T, Steinvil A, Torguson R, Waksman R, et al
    Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the AngelMed Guardian System.
    Circulation. 2016;134:262-4.
    >> Share

  362. KEREIAKES DJ, Onuma Y, Serruys PW, Stone GW, et al
    Bioresorbable Vascular Scaffolds for Coronary Revascularization.
    Circulation. 2016;134:168-82.
    >> Share

  363. SERRUYS PW, Rutherford JD
    The Birth, and Evolution, of Percutaneous Coronary Interventions: A Conversation With Patrick Serruys, MD, PhD.
    Circulation. 2016;134:97-100.
    >> Share

  364. GRISANTI LA, Gumpert AM, Traynham CJ, Gorsky JE, et al
    Leukocyte-Expressed beta2-Adrenergic Receptors Are Essential for Survival After Acute Myocardial Injury.
    Circulation. 2016;134:153-67.
    >> Share

  365. RYDEN L
    Response by Ryden to Letter Regarding Article, "Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study".
    Circulation. 2016;134:e2.
    >> Share

  366. DIZMAN N, Cakir IB, Oguz A
    Letter by Dizman et al Regarding Article, "Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study".
    Circulation. 2016;134:e1.
    >> Share

  367. PERAK AM, Ning H, de Ferranti SD, Gooding HC, et al
    Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
    Circulation. 2016;134:9-19.
    >> Share

  368. SHAH SJ, Kitzman DW, Borlaug BA, van Heerebeek L, et al
    Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Circulation. 2016;134:73-90.
    >> Share

  369. RODRIGUEZ F, Knowles JW
    Enough Evidence, Time to Act!
    Circulation. 2016;134:20-3.
    >> Share

    June 2016
  370. RUMSFELD JS, Brooks SC, Aufderheide TP, Leary M, et al
    Use of Mobile Devices, Social Media, and Crowdsourcing as Digital Strategies to Improve Emergency Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Jun 22. pii: CIR.0000000000000428.
    >> Share

  371. FAXON DP, Williams DO
    Interventional Cardiology: Current Status and Future Directions in Coronary Disease and Valvular Heart Disease.
    Circulation. 2016;133:2697-711.
    >> Share

  372. BROWN DW, MacRae CA, Gardner TJ
    The Future of Cardiovascular Education and Training.
    Circulation. 2016;133:2734-42.
    >> Share

  373. SHEMIN RJ
    The Future of Cardiovascular Surgery.
    Circulation. 2016;133:2712-5.
    >> Share

  374. SOLOMON SD, Pfeffer MA
    The Future of Clinical Trials in Cardiovascular Medicine.
    Circulation. 2016;133:2662-70.
    >> Share

  375. DI CARLI MF, Geva T, Davidoff R
    The Future of Cardiovascular Imaging.
    Circulation. 2016;133:2640-61.
    >> Share

  376. VASAN RS, Benjamin EJ
    The Future of Cardiovascular Epidemiology.
    Circulation. 2016;133:2626-33.
    >> Share

  377. LEE RT, Walsh K
    The Future of Cardiovascular Regenerative Medicine.
    Circulation. 2016;133:2618-25.
    >> Share

  378. MACRAE CA, Roden DM, Loscalzo J
    The Future of Cardiovascular Therapeutics.
    Circulation. 2016;133:2610-7.
    >> Share

  379. MACRAE CA, Loscalzo J
    The Future of Cardiovascular Biomedicine.
    Circulation. 2016;133:2601-2.
    >> Share

  380. LU Y, Ezzati M, Rimm EB, Hajifathalian K, et al
    Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United States.
    Circulation. 2016 Jun 20. pii: CIRCULATIONAHA.115.018102.
    >> Share

  381. CARRERAS ET, Chatzizisis YS, Mauri L, MacRae C, et al
    Acute Coronary Syndrome in a 52-Year-Old Woman With Scleroderma.
    Circulation. 2016;133:2576-82.
    >> Share

  382. KWAN GF, Mayosi BM, Mocumbi AO, Miranda JJ, et al
    Endemic Cardiovascular Diseases of the Poorest Billion.
    Circulation. 2016;133:2561-75.
    >> Share

  383. WU Y, Benjamin EJ, MacMahon S
    Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China.
    Circulation. 2016;133:2545-60.
    >> Share

  384. MENDES M
    Is There a Role for Cardiac Rehabilitation After Coronary Artery Bypass Grafting? There is No Role for Cardiac Rehabilitation After Coronary Artery Bypass Grafting.
    Circulation. 2016;133:2538-43.
    >> Share

  385. NIEBAUER J
    Is There a Role for Cardiac Rehabilitation After Coronary Artery Bypass Grafting? Treatment After Coronary Artery Bypass Surgery Remains Incomplete Without Rehabilitation.
    Circulation. 2016;133:2529-37.
    >> Share

  386. LOW WANG CC, Hess CN, Hiatt WR, Goldfine AB, et al
    Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.
    Circulation. 2016;133:2459-502.
    >> Share

  387. ZONG G, Gao A, Hu FB, Sun Q, et al
    Whole Grain Intake and Mortality From All Causes, Cardiovascular Disease, and Cancer: A Meta-Analysis of Prospective Cohort Studies.
    Circulation. 2016;133:2370-80.
    >> Share

  388. MITTER SS, Vedanthan R, Islami F, Pourshams A, et al
    Household Fuel Use and Cardiovascular Disease Mortality: Golestan Cohort Study.
    Circulation. 2016;133:2360-9.
    >> Share

  389. SAMET JM, Bahrami H, Berhane K
    Indoor Air Pollution and Cardiovascular Disease: New Evidence From Iran.
    Circulation. 2016;133:2342-4.
    >> Share

  390. TZOULAKI I, Elliott P, Kontis V, Ezzati M, et al
    Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects: Current Knowledge and Data Gaps.
    Circulation. 2016;133:2314-33.
    >> Share

    May 2016
  391. PATEL RS, Ghasemzadeh N, Eapen DJ, Sher S, et al
    Response to Letter Regarding Article "Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease".
    Circulation. 2016;133:e667.
    >> Share

  392. HOANG S, Girerd X, Giral P
    Letter by Hoang et al Regarding Article, "Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease".
    Circulation. 2016;133:e666.
    >> Share

  393. GEWIRTZ H, Dilsizian V
    Integration of Quantitative Positron Emission Tomography Absolute Myocardial Blood Flow Measurements in the Clinical Management of Coronary Artery Disease.
    Circulation. 2016;133:2180-96.
    >> Share

  394. BAGAI A, Bhatt DL, Eikelboom JW, Mancini GB, et al
    Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.
    Circulation. 2016;133:2094-8.
    >> Share

  395. WIRTZ VJ, Kaplan WA, Kwan GF, Laing RO, et al
    Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries.
    Circulation. 2016;133:2076-85.
    >> Share

  396. SCHULMAN-MARCUS J, Boden WE
    A PROMISE Fulfilled That Quality-of-Life Assessments Afford Incremental Value to Coronary Artery Disease Management.
    Circulation. 2016;133:1989-91.
    >> Share

  397. MYERSON SG, d'Arcy J, Christiansen JP, Dobson LE, et al
    Determination of Clinical Outcome in Mitral Regurgitation With Cardiovascular Magnetic Resonance Quantitation.
    Circulation. 2016 May 17. pii: CIRCULATIONAHA.115.017888.
    >> Share


  398. ECG Response: May 17, 2016.
    Circulation. 2016;133:1984.
    >> Share

  399. BENSON MD, Lapedis CJ, Adler DS, Feinberg MW, et al
    Bulging at the Root: An Inflammatory Tale.
    Circulation. 2016;133:1969-77.
    >> Share

  400. BITTENCOURT MS, Hulten EA, Veeranna V, Blankstein R, et al
    Coronary Computed Tomography Angiography in the Evaluation of Chest Pain of Suspected Cardiac Origin.
    Circulation. 2016;133:1963-8.
    >> Share

  401. ZHANG ZM, Rautaharju PM, Prineas RJ, Rodriguez CJ, et al
    Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.
    Circulation. 2016 May 16. pii: CIRCULATIONAHA.115.021177.
    >> Share

  402. LEE CH, Sethi R, Li R, Ho HH, et al
    Obstructive Sleep Apnea and Cardiovascular Events After Percutaneous Coronary Intervention.
    Circulation. 2016 May 13. pii: CIRCULATIONAHA.115.019392.
    >> Share

  403. SACCO RL, Roth GA, Reddy KS, Arnett DK, et al
    The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Circulation. 2016 May 9. pii: CIR.0000000000000395.
    >> Share

  404. VITAL SA, Becker F, Holloway PM, Russell J, et al
    Fpr2/ALX Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.115.020633.
    >> Share

  405. GULATI R, Gersh BJ
    Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction: Do We Have the Evidence?
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.116.022733.
    >> Share

  406. BANGALORE S, Guo Y, Samadashvili Z, Blecker S, et al
    Revascularization in Patients with Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus Eluting Stents vs. Coronary Artery Bypass Graft Surgery.
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.115.021168.
    >> Share

  407. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans.
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.116.021700.
    >> Share


  408. ECG Response: May 3, 2016.
    Circulation. 2016;133:1827.
    >> Share

    April 2016
  409. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    >> Share

  410. ONORATO A, Sturm AC
    Heterozygous Familial Hypercholesterolemia.
    Circulation. 2016;133:e587-9.
    >> Share

  411. BLUMENTHAL JA, Sherwood A, Smith PJ, Watkins L, et al
    Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial.
    Circulation. 2016;133:1341-50.
    >> Share

    March 2016
  412. BOHULA EA, Giugliano RP, Cannon CP, Zhou J, et al
    Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-I
    Circulation. 2016;133:e463.
    >> Share

  413. HIBBS J, Orlandi Q, Olivari MT, Dickey W, et al
    Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension.
    Circulation. 2016;133:1132-4.
    >> Share

  414. LAU ES, O'Donoghue ML, Hamilton MA, Goldhaber SZ, et al
    Women and Heart Attacks.
    Circulation. 2016;133:e428-9.
    >> Share

  415. SANTOS-GALLEGO CG, Vahl TP, Goliasch G, Picatoste B, et al
    Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Circulation. 2016;133:954-66.
    >> Share

  416. BONACA MP, Gutierrez JA, Creager MA, Scirica BM, et al
    Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Inf
    Circulation. 2016;133:997-1005.
    >> Share

    February 2016
  417. ALEXANDER KM, Veillet-Chowdhury MR, MacIntyre CJ, Loscalzo J, et al
    A Shocking Development in a Young Male Athlete With Chest Pain.
    Circulation. 2016;133:756-63.
    >> Share

    January 2016
  418. HARSKAMP RE, Alexander JH, Ferguson TB Jr, Hager R, et al
    Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.
    Circulation. 2016;133:131-8.
    >> Share

    December 2015
  419. FIGUEROA JF, Joynt KE
    Unplanned Rehospitalizations and Depression: Time for a New Approach?
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.020528.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016